Currently, there is also a concomitant conflicting thought process going on in a recent study of patients with breast cancer published by Lodola et al. Their findings indicated that the intracellular Ca2+ toolkit is responsible for the pro-angiogenic effect of VEGF and is remodeled in cancer patients and rendered insensitive to VEGF. This evidence concerns the gene VEGFA and breast cancer.